Publication Author: Ezekowitz JA
Filter by Author:
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial.
Butler J, Fioretti F, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Teixeira PP, Ezekowitz JA, Gates D, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Zannad F.
Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification.
O'Connor CM, Rathwell S, Mehrotra DV, Corda S, McMullan CJ, Lam CSP, Ezekowitz JA, Piekse B, Hernandez AF, Anstrom KJ, Mentz RJ, deFilippi CR, Voors A, Ponikowski P, Butler J, Westerhout CM, Armstrong PW; VICTORIA Study Group.
Time-to-Diuretics in Acute Heart Failure Management: Striking the Balance between “Speed” versus “Accuracy”.
Alam-Shoushtari S, Hawkins NM, McKelvie R, Poon S, Honos G, Zieroth S, Ezekowitz J, Virani SA, Moghaddam N.
Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement.
Rosano G, Ezekowitz J, Nemeth E, Ponikowski P, Rauner M, Seid M, Spahn DR, Stein J, Wish J, Mentz RJ.
Device Therapy in Patients with Heart Failure: Is Medication Use Optimized and Are We Targeting Those Patients Most Likely to Benefit?
Wannamaker R, Sandhu RK, Ezekowitz JA, Koshman SL, Chew DS, Gagnon LR, Ma CH, Sadasivan C, Oudit GY, McAlister FA
Geographic Variation and Human Development Index in Heart Failure With Reduced Ejection Fraction: Insights From VICTORIA.
Cohen-Solal A, Alemayehu W, Lam CSP, Tsutsui H, Zhang J, Godoy-Palomino A, Tziakas DN, Corda S, McMullan CJ, Ezekowitz JA, Hernandez AF, Pieske B, O'Connor CM, Westerhout CM, Armstrong PW; VICTORIA Study Group.
Guideline-Directed Medical Therapy Use in the STRONG-HF Trial.
Zhang X, Davison B, Adamo M, Arrigo M, Biegus J, Chioncel O, Cohen-Solal A, Cotter G, Edwards C, Kimmoun A, Lam CSP, Mebazaa A, Metra M, Novosadova M, Pang PS, Sliwa K, Takagi K, Voors AA, Ezekowitz JA.
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND study.
Kalogeropoulos AP, Hameed I, Anker SD, Bayes-Genis A, Böhm M, Budden J, Cleland JGF, Coats AJS, Ezekowitz JA, Filippatos G, Goudev A, Khan MS, Lindenfeld J, Lund LH, Merkely B, Mentz RJ, Metra M, Moutchia J, Perrin A, Ponikowski P, Priest EL, Rossignol P, Senni M, Shaver C, Waechter S, Weir MR, Pitt B, Butler J.
Review of Transcatheter Aortic Valve Insertion (TAVI) Clinician Opinions on the Canadian Cardiovascular Society Post-TAVI Driving Guidelines.
Jarvis CR, Gouda P, Ezekowitz J, Van Spall HGC, Tyrrell B, Welsh RC.
iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025.
Chopra V, Khan MS, Abdelhamid M, Abraham WT, Amir O, Anker SD, Atherton JJ, Bacal F, von Bardeleben RS, Brito D, Burgos LM, Butler J, Costanzo MR, Damasceno A, Ezekowitz JA, Hameed I, Harikrishnan S, Jaarsma T, Lala A, Piña IL, Saldarriaga C, Sim D, Teerlink JR, Tsabedze N, Tsutsui H, Yu J, Zhang Y, Zubaid M, Balankhe N, Gomez-Mesa JE, Januzzi JL, Konstam M, Monroe R, Ogola E, Palaniappan V, Petrie MC, Pinto FJ, Rajadhyaksha GC, Rakisheva A, Ramos CE, Rossel V, Sato N, Schulze PC, Sindone A, Skouri HN, Van Spall HGC, Štaraitė A, Stevenson LW, Sulaiman K, Wang TD, Böhm M, Coats AJS, Zieroth S.
Implantable cardioverter-defibrillators in ischaemic versus non-ischaemic heart failure: Insights from the VICTORIA trial.
Gouda P, Alemayehu W, Voors AA, Lam CSP, Ezekowitz J, Pieske B, Butler J, Westerhout CM, Yogasundaram H, Sandhu RK, Armstrong PW; on behalf of the VICTORIA Study Group.
Revisiting ICD Therapy for Primary Prevention: The CONTEMP-ICD Trial.
Goldenberg I, Ezekowitz JA, Butler J.
Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF Study.
Blumer V, Januzzi JL Jr, Liu Y, Butler J, Ezekowitz JA, Perfetti R, Rosenstock J, Del Prato S, Tang WHW, Urbinati A, Zannad F, Lewis GD, Solomon SD, Hedge S, Ibrahim NE, Lam CSP.
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HF.
Siddiqi TJ, Liu Y, Zannad F, Tang WHW, Solomon S, Rosenstock J, Perfetti R, Marwick TH, Lewis GD, Lam CSP, Ibrahim NE, Ezekowitz J, Del Prato S, Butler J, Januzzi JL.
Dual Pathway Inhibition in Patients with Atherosclerosis with or without Heart Failure: Insights from the XATOA Registry
Gouda, Pishoy Ezekowitz, Justin A. Gay, Alain Vogtländer, Kai Aboyans, Victor Debus, Sebastian Fox, Keith Zeymer, Uwe Welsh, Robert
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial.
Saldarriaga CI, Zannad F, McMullan CJ, Xing A, Gates D, Anstrom KJ, Bonaca MP, Corda S, Ezekowitz JA, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O'Connor C, Patel M, Ponikowski P, Reddy YNV, Rosano GMC, Senni M, Udelson J, Voors AA, Butler J.
Heterogeneity in Treatment Effects in the Reduction of Dietary Sodium to Less than 100 mmol in Heart Failure (SODIUM-HF): A Secondary Post-hoc Analysis.
Zampieri FG, Rathwell S, McAlister FA, Ross H, Escobedo J, Saldarriaga C, Colin-Ramirez E, Troughton RW, Macdonald P, Alemayehu W, Ezekowitz JA; SODIUM-HF Investigators.
Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure.
Goldenberg I, Ezekowitz J, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Hsich E, Huang DT, Januzzi JL, Kutyifa V, Lala A, Onwuanyi A, Piña IL, Sandhu RK, Sears S, Sroubek J, Strawderman R, Zareba W, Butler J.
Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing Subanalysis.
Tang WHW, Liu Y, Butler J, Del Prato S, Ezekowitz JA, Ibrahim NE, Lam CSP, Marwick TH, Perfetti R, Rosenstock J, Solomon SD, Zannad F, Januzzi JL, Lewis GD.
Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial.
Ezekowitz JA, Mulder H, Mentz RJ, Butler J, De Pasquale CG, Lewis GD, O'Meara E, Ponikowski P, Troughton RW, Wong YW, Adamczyk R, Numan S, Blackman N, Rockhold FW, Hernandez AF.
